- Zimmer Biomet press release (NYSE:ZBH): Q2 Non-GAAP EPS of $2.07 beats by $0.09.
- Revenue of $2.08B (+7.2% Y/Y) beats by $20M.
- FY25 revenue growth consensus of 6.48%, EPS consensus of $7.99
Projected Year Ending December 31, 2025
Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.09, revenue of $2.08B beats by $20M
2 days ago
1
Related
Ousted vaccine regulator Vinay Prasad to return to FDA
6 hours ago
2
White House crypto adviser Bo Hines announces departure
10 hours ago
0
Trending stocks in a strong week for Wall Street
10 hours ago
1
English (US) ·